Results 101 to 110 of about 38,385 (190)

Identification and Quantification of a Pneumococcal Cell Wall Polysaccharide by Antibody-Enhanced Chromatography Assay

Vaccines
Multivalent pneumococcal vaccines have been developed successfully to combat invasive pneumococcal diseases (IPD) and reduce the associated healthcare burden.
James Z. Deng, Zhifeng Chen, James Small, Yue Yuan, Kara Cox, Aimin Tang, Jeanette Roman, Liming Guan, Katrina Feller, Frances Ansbro, Kalpit Vora   +10 more
doaj   +1 more source

Response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children. • 686 [PDF]

, 1997
Elizabeth D. Barnett, Stephen I. Pelton, Roland D. Eavey, Jerome O. Klein, Carole Allen, Howard Cabral, E. R. McNamara, Michael J. Cunningham   +7 more
openalex   +1 more source

Approaches to vaccination of adults against pneumococcal disease in different countries of the world

Журнал инфектологии
Various pneumococcal vaccines are available worldwide, differing in the range of serotypes coverage and type of vaccine, which determine different mechanisms of action and postvaccinal immunity. Vaccination  against  pneumococcal infection is recommended
A. S. Korovkin, Yu. I. Obukhov, E. N. Syatchikhina   +2 more
doaj   +1 more source

Simultaneous Influenza and Pneumococcal Vaccines [PDF]

, 1996
Gina Pugliese
openalex   +1 more source

Fusion of PspA to detoxified pneumolysin enhances pneumococcal vaccine coverage. [PDF]

PLoS One, 2023
Milani B, Dos Santos TW, Guerra MES, Oliveira S, Goulart C, André GO, Leite LCC, Converso TR, Darrieux M.   +8 more
europepmc   +1 more source

Pneumococcal Vaccine Response in Cirrhosis and Liver Transplantation [PDF]

, 2000
Timothy M. McCashland, Laurel C. Preheim, Martha J. Gentry   +2 more
openalex   +1 more source

Heterogeneous population and its resilience to misinformation in vaccination uptake: A dual ODE and network approach [PDF]

arXiv
Misinformation about vaccination poses a significant public health threat by reducing vaccination rates and increasing disease burden. Understanding population heterogeneity can aid in recognizing and mitigating the effects of such misinformation, especially when vaccine effectiveness is low.
arxiv  

Studies on Clinical Application of Pneumococcal Vaccine

, 1984
HIDEO FUKUMI, Yoshinori Kaneko, Tosihiko AGATA, Makiko TAKAYANAGI, Hajime Yoshioka, Kozo Fujita, R Kawana, Kaoru Shimada, Takashi Inamatsu, Kyoko URAYAMA, Hiroichi Tanimoto, Tatsuo Nakatani, Nozomu KOZAKAI, Toyoko Oguri, Hideo IKEMOTO, Kota Okinaga, Mikio Kimura, Shunichi Kato, Seiichiro MURANAKA, Suzuko Uehara, I Terashima, Akira Nakamura, Yutaka Nishimura, Muneharu YAMAMOTO, Riichiro Mikami, Masayoshi Sawaki, Osamu HARIKANE, Hiroshi Hashimoto, Keizō Matsumoto, Hiroshi Suzuki, Kohei Hara, Keizo Yamaguchi, Masumi Matsuse, Tomokazu Kishaba, Motonori FUJIHARA, Iwao TANABE, Tadanori MORIGAKI, Yasushi Togo   +37 more
openalex   +2 more sources

The Contribution of Specific Pneumococcal Serogroups to Different Disease Manifestations: Implications for Conjugate Vaccine Formulation and Use, Part II [PDF]

, 2000
William P. Hausdorff, John Bryant, C. Kloek, Peter R. Paradiso, George R. Siber   +4 more
openalex   +1 more source

Serotype distribution of Streptococcus pneumoniae and pneumococcal vaccine coverage in adults in Turkey between 2015 and 2018. [PDF]

Ann Med, 2023
Hascelik G, Soyletir G, Gulay Z, Sancak B, Yaman A, Gurler N, Aydemir SS, Bayramoglu G, Aydin F, Cekin Y, Birinci A, Ozakin C, Akpolat N, Ozhak Baysan B, Gultekin M, Zer Y, Sanal L, Arabaci C, Ay Altintop Y, Ozturk C, Ceyhan M.   +20 more
europepmc   +1 more source